Mary Kay To Pay $40M Over Wrinkle Cream Patent

Law360, New York (April 6, 2006, 12:00 AM EDT) -- Makeup retailer Mary Kay Inc. has been orderd by a jury to pay TriStrata Technology Inc. $40 million for allegedly infringing patents for its skin care remedy used to treat wrinkles.

TriStrata, a subsidiary of NeoStrata Co., originally filed the lawsuit in 2001, accusing Mary Kay of using its patented alpha hydroxy acid technology.

In March 2005, a jury ordered Mary Kay to pay more than $26 million in backend royalties to Delaware-based TriStrata. TriStrata returned to court to seek interest on that amount.

The total...
To view the full article, register now.